Thalassemia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
Line 7: | Line 7: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{| class="wikitable" | |||
!Characteristic/Parameter | |||
!Etiology | |||
!Mean corpuscular volume | |||
!Laboratory abnormalities | |||
!Physical examination | |||
!Treatment | |||
!Other associated abnormalities | |||
|- | |||
|Hemolytic anemia | |||
| | |||
* [[Drug-induced]] | |||
* [[Immune-mediated disease|Immune-mediated]] | |||
* Non-immune-mediated | |||
* [[Infections]] | |||
* [[Rheumatologic disease]] | |||
| | |||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | |||
| | |||
* Indirect [[hyperbilirubinemia]] | |||
* [[Reticulocytosis]] | |||
* Low [[haptoglobin]] | |||
* Elevated [[LDH]] | |||
| | |||
* [[Pallor]] | |||
* [[Jaundice]] | |||
| | |||
* Removal of offending agent | |||
* [[Steroids]] | |||
* Alternative [[immunosuppression]] | |||
| | |||
* [[HELLP syndrome]] | |||
* [[TTP]] | |||
* [[Chronic lymphocytic leukemia|CLL]] | |||
|- | |||
|[[Sideroblastic anemia]] | |||
| | |||
* [[Alcoholism]] | |||
* [[Lead poisoning]] | |||
* [[Vitamin B6 deficiency]] | |||
* [[Isoniazid]] | |||
* [[Chloramphenicol]] | |||
| | |||
* [[Microcytic anemia|Microcytic]] (<80 femtoliter) | |||
Or | |||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | |||
| | |||
* Ringed sideroblasts in [[bone marrow]] | |||
* Low [[vitamin B6]] level | |||
* High [[lead]] level | |||
| | |||
* [[Pallor]] | |||
* [[Muscle weakness|Weakness]] | |||
| | |||
* Removal of offending [[medication]] | |||
* High-dose [[vitamin B6]] (up to 200mg daily) | |||
* Avoidance of [[splenectomy]] | |||
* Symptomatic [[Blood transfusion|transfusion]] support with [[iron]] [[chelation]] as needed | |||
| | |||
* [[Myelodysplastic syndrome]] | |||
* [[Myeloproliferative neoplasm]] | |||
* [[Iron overload]] | |||
|- | |||
|[[Anemia of chronic disease]] | |||
| | |||
* [[Chronic kidney disease]] | |||
* [[Rheumatologic disease]] | |||
* [[Cancer]] | |||
* [[HIV]] | |||
* Chronic infection; excess release of [[IL-1]] and [[IL-6]] | |||
| | |||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | |||
| | |||
* Elevated [[ESR]] and [[CRP]] | |||
* Elevated [[hepcidin]] | |||
* Low serum [[iron]] | |||
* Low [[transferrin]] | |||
* Elevated [[ferritin]] | |||
| | |||
* [[Pallor]] | |||
* [[Weakness]] | |||
| | |||
* Treatment of the underlying cause; [[erythropoiesis]]-stimulating agents | |||
* Supportive [[Red blood cell transfusion|red blood cell transfusions]] | |||
| | |||
* [[Inflammatory bowel disease]] | |||
|- | |||
|[[Thalassemia]] | |||
| | |||
* [[Genetic defect]] with alpha- or [[beta-globin]] production | |||
| | |||
* [[Microcytic]] (<80 femtoliter) | |||
| | |||
* Abnormal [[hemoglobin]] [[electrophoresis]] (in [[beta-thalassemia]]) | |||
| | |||
* [[Irritability]] | |||
* [[Growth retardation]] | |||
* [[Jaundice]] | |||
* [[Hepatomegaly]] | |||
* [[Splenomegaly]] | |||
| | |||
* [[Blood transfusion|Transfusion]] support | |||
* [[Iron]] chelation | |||
* [[Gene therapy]] if available | |||
| | |||
* [[Extramedullary hematopoiesis]] | |||
|- | |||
|[[Iron deficiency anemia]] | |||
| | |||
* Loss of [[iron]] from [[gastrointestinal]] blood loss or [[menstrual]] [[blood loss]] | |||
| | |||
* [[Microcytic]] (<80 femtoliter) | |||
| | |||
* Low serum [[iron]] | |||
* Elevated [[transferrin]] | |||
* Low [[transferrin saturation]] | |||
* Low [[ferritin]] | |||
| | |||
* [[Pallor]] | |||
* [[Weakness]] | |||
* Positive [[occult blood]] testing (if [[Gastrointestinal bleeding|GI bleeding]]) | |||
| | |||
* Intravenous or oral iron supplementation | |||
| | |||
* [[Blood loss|Chronic blood loss]] | |||
|- | |||
|[[Erythropoietin]] deficiency | |||
| | |||
* [[Chronic kidney disease]] or other [[renal dysfunction]] | |||
| | |||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | |||
| | |||
* Low [[Erythropoietin|erythropoietin level]] | |||
| | |||
* [[Pallor]] | |||
* [[Weakness]] | |||
* Signs of [[chronic kidney disease]] | |||
| | |||
* [[Epoetin alfa]] 50-100 units/kg 3 times weekly | |||
* Darbepoietin 0.45 mcg/kg weekly or 0.75 mcg/kg every 2 weeks<ref name="pmid28626220">{{cite journal| author=Platzbecker U, Symeonidis A, Oliva EN, Goede JS, Delforge M, Mayer J et al.| title=A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes. | journal=Leukemia | year= 2017 | volume= 31 | issue= 9 | pages= 1944-1950 | pmid=28626220 | doi=10.1038/leu.2017.192 | pmc=5596208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28626220 }} </ref> | |||
| | |||
* [[Dialysis]] dependence | |||
* [[Myelodysplastic syndrome]] | |||
|- | |||
|[[Vitamin B12 deficiency|Vitamin B12]] or [[folate deficiency]] | |||
| | |||
* [[Pernicious anemia]] | |||
* [[Diphyllobothrium latum infection]] | |||
* [[Nutritional deficiency]] | |||
* [[Crohn's disease|Crohn's disease of terminal ileum]] | |||
| | |||
* [[Macrocytic anemia|Macrocytic]] (>100 femtoliter) | |||
| | |||
* Low vitamin B12 or folate level | |||
* [[Megaloblastic anemia]] with hypersegmented [[neutrophils]] | |||
| | |||
* [[Numbness]] | |||
* [[Weakness]] | |||
* [[Tingling]] | |||
* [[Paresthesias]] | |||
| | |||
* [[Vitamin B12]] 1000mcg daily | |||
* [[Folate]] 1mg daily | |||
| | |||
* [[Neuropathy]] | |||
|} | |||
==References== | ==References== |
Revision as of 04:57, 15 November 2017
Thalassemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thalassemia differential diagnosis On the Web |
American Roentgen Ray Society Images of Thalassemia differential diagnosis |
Risk calculators and risk factors for Thalassemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Differential Diagnosis
Characteristic/Parameter | Etiology | Mean corpuscular volume | Laboratory abnormalities | Physical examination | Treatment | Other associated abnormalities |
---|---|---|---|---|---|---|
Hemolytic anemia |
|
|
|
|
||
Sideroblastic anemia |
Or
|
|
|
|||
Anemia of chronic disease |
|
|
|
|||
Thalassemia |
|
|
|
|
||
Iron deficiency anemia |
|
|
|
|
|
|
Erythropoietin deficiency |
|
|
|
|
| |
Vitamin B12 or folate deficiency |
|
|
|
References
- ↑ Platzbecker U, Symeonidis A, Oliva EN, Goede JS, Delforge M, Mayer J; et al. (2017). "A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes". Leukemia. 31 (9): 1944–1950. doi:10.1038/leu.2017.192. PMC 5596208. PMID 28626220.